News and Announcements

GSK to sell remaining 4.2% stake in Haleon

By Michele Maatouk

Date: Thursday 16 May 2024

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
The pharmaceutical company will sell about 385m ordinary shares in consumer health business Haleon, which it spun off in July 2022.

GSK initially retained a 12.9% stake in Haleon, but has...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page